COAPT Score (MitraClip Responder Model) Calculator

Clinical calculation support · Verify results before clinical use

Clinical and echocardiographic inputs

Enter the patient's findings to calculate the point-based COAPT Risk Score.

—Score

Clinical variables

COPD history.

History of atrial fibrillation or flutter.

NYHA III or IVa contributes 1 point.

Use the model's eGFR categories; confirm the clinical context and renal status.

Echocardiographic variables

Enter the dimension in centimetres. More than 5.5 cm contributes 2 points.

Enter mmHg. RVSP >45 mmHg contributes 3 points when estimable.

TR grade ≥2+ contributes 2 points.

Treatment variable

This term represents treatment in the published prognostic model. It is not, by itself, a recommendation to perform TEER.

Reset

About the COAPT Risk Score

The COAPT Risk Score is a point-based prognostic model derived from the COAPT trial database. It was developed to estimate the 2-year risk of the composite of all-cause death or heart failure hospitalization among patients with heart failure and significant secondary mitral regurgitation.

The model combines clinical variables, echocardiographic findings, and the M-TEER treatment term. Its use should remain within the context of the population and endpoint for which it was developed.

Score components

VariableModel criterionPoints
COPDPresent+1
Atrial fibrillation/flutterPresent+1
NYHA classIII or IVa+1
eGFR30–60 / <30 or ESRD+1 / +3
LVEF25–35% / <25%+1 / +2
LVESD>5.5 cm+2
RVSP>45 mmHg+3
TR grade≥2++2
M-TEER treatment termSelected−3

Clinical interpretation

This calculator displays the sum of the published point weights represented in this implementation. It does not calculate an absolute probability or replace the original model's full statistical specification.

  • Use alongside clinical assessment, echocardiographic evaluation, GDMT optimization, anatomy, comorbidities, and shared decision-making.
  • Do not use the score alone to determine eligibility for M-TEER or to withhold treatment.
  • External validation reported variable discrimination across patient subgroups; applicability outside COAPT-like populations requires caution.

References

Shah N, Madhavan MV, Gray WA, et al. Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk Score.JACC: Cardiovascular Interventions. 2022;15(19):1893–1905.https://doi.org/10.1016/j.jcin.2022.08.005
Adamo M, et al. Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score.European Heart Journal – Cardiovascular Imaging. 2023.Read external validation study
Important model limitation: The published score was developed using a specific clinical-trial population and a 2-year composite outcome. This calculator reproduces the point weights documented in the source code and accessible publication summaries; it does not reproduce a calibrated individualized event probability. Confirm the exact scoring specification against the full original article and supplement before using for clinical decisions.
Disclaimer: This tool is intended for clinical education and decision support, not as a substitute for professional judgment, local protocols, or a multidisciplinary Heart Team assessment. Verify input data and the applicability of the model to the patient. Clinical decisions should not be based on this score alone.